knowledge -WSS

knowledge

author：explore 2025-09-30 09:29:32 - browse：13335

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： FDA's naming rule on biosimilars has undermined competition

WSS

Blinken talks high

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

The debate over Covid

Patient advocates debate FDA's accelerated approval process

Will generative AI in health care meet the fate of IBM's Dr. Watson?

How are insurers handling Leqembi and related scans?

focus

knowledge

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Britney Spears to release memoir, 'The Woman In Me,' later this year

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Scientists boost immune system in aging mice by making it youthful

23andMe had bad news about my health. I wish a person had delivered it

Vermont grapples with historic flooding as more rainstorms head for Northeast

How one medical school became remarkably diverse

Sickle cell gene therapy cures need to be accessible in Africa

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

focus

Britney Spears to release memoir, 'The Woman In Me,' later this year

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Steward Health Care has deal to sell doctor network to UnitedHealth

One Duchenne patient's bittersweet hope for new treatment

Washington mulls new rules to avert another Change Healthcare

France's anti

leisure time

Wikipedia

explore

explore